A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The aims of this study are to evaluate:
- The safety and tolerability of a single dose of treprostinil given subcutaneously (as an
injection just under the skin)
- The pharmacokinetic profile (how the body absorbs, breaks down, and gets rid of) of a
single subcutaneous dose of a new LY900014 formulation in healthy Japanese participants.
The study has two parts. Participants may only enroll in one part.